Anúncio
Anúncio
ASTH
Astrana Health Inc. Common Stock
28.22
USDPatrocinado
+0.06
+0.21%
08 de jan., 16:00 UTC -5
Encerrado
Pré-Mercado
28.25
+0.03
+0.09%
Relatórios de Lucros ASTH
Rácio de surpresa positiva
ASTH separação 18 de 30 últimas estimativas.
60%
Próximo Relatório
Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$949.07M
/$0.10
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-0.73%
/+900.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+42.67%
/-166.67%
Astrana Health Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, ASTH reported earnings of 0.01 USD per share (EPS) for Q3 25, missing the estimate of 0.45 USD, resulting in a -97.78% surprise. Revenue reached 956.05 milhão, compared to an expected 971.84 milhão, with a -1.63% difference. The market reacted with a -23.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of 0.10 USD, with revenue projected to reach 949.07 milhão USD, implying an aumentar of 900.00% EPS, and diminuir of -0.73% in Revenue from the last quarter.
FAQ
What were Astrana Health Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Astrana Health Inc. Common Stock reported EPS of $0.01, missing estimates by -97.78%, and revenue of $956.05M, -1.63% below expectations.
How did the market react to Astrana Health Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -23.46%, changed from $33.36 before the earnings release to $25.54 the day after.
When is Astrana Health Inc. Common Stock expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for Astrana Health Inc. Common Stock's next earnings report?
Based on 12
analistas, Astrana Health Inc. Common Stock is expected to report EPS of $0.10 and revenue of $949.07M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio